nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—HTR1A—Penbutolol—coronary artery disease	0.68	1	CbGbCtD
Lofexidine—Clonidine—SLC22A3—coronary artery disease	0.00624	1	CrCbGaD
Lofexidine—HTR1A—Signaling Pathways—PSMA6—coronary artery disease	8.6e-05	0.000274	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CSF2—coronary artery disease	8.59e-05	0.000274	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—F2—coronary artery disease	8.58e-05	0.000274	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SDC1—coronary artery disease	8.56e-05	0.000273	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS3—coronary artery disease	8.48e-05	0.000271	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGT—coronary artery disease	8.43e-05	0.000269	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDE4B—coronary artery disease	8.41e-05	0.000269	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CYBB—coronary artery disease	8.41e-05	0.000269	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCL8—coronary artery disease	8.41e-05	0.000268	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MMP3—coronary artery disease	8.39e-05	0.000268	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EDNRA—coronary artery disease	8.33e-05	0.000266	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB1—coronary artery disease	8.29e-05	0.000265	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CYBA—coronary artery disease	8.29e-05	0.000265	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DUSP6—coronary artery disease	8.25e-05	0.000263	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—JAK2—coronary artery disease	8.24e-05	0.000263	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLAT—coronary artery disease	8.11e-05	0.000259	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PSMA6—coronary artery disease	8.08e-05	0.000258	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PSMB5—coronary artery disease	8.08e-05	0.000258	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EDN1—coronary artery disease	7.98e-05	0.000255	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL5—coronary artery disease	7.92e-05	0.000253	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CTGF—coronary artery disease	7.9e-05	0.000252	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PRKCD—coronary artery disease	7.86e-05	0.000251	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL12—coronary artery disease	7.83e-05	0.00025	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BDKRB2—coronary artery disease	7.83e-05	0.00025	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMGCR—coronary artery disease	7.83e-05	0.00025	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GOT2—coronary artery disease	7.83e-05	0.00025	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—POMC—coronary artery disease	7.82e-05	0.000249	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CSF2—coronary artery disease	7.8e-05	0.000249	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—F2—coronary artery disease	7.79e-05	0.000249	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6ST—coronary artery disease	7.76e-05	0.000248	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR3—coronary artery disease	7.7e-05	0.000246	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2A—coronary artery disease	7.69e-05	0.000246	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JUNB—coronary artery disease	7.68e-05	0.000245	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—C3—coronary artery disease	7.68e-05	0.000245	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLCB1—coronary artery disease	7.66e-05	0.000244	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CRK—coronary artery disease	7.6e-05	0.000242	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	7.56e-05	0.000241	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VWF—coronary artery disease	7.5e-05	0.000239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ATP2A2—coronary artery disease	7.5e-05	0.000239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SH2B3—coronary artery disease	7.5e-05	0.000239	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR7—coronary artery disease	7.5e-05	0.000239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOC3—coronary artery disease	7.45e-05	0.000238	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LDLR—coronary artery disease	7.41e-05	0.000236	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGT—coronary artery disease	7.3e-05	0.000233	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PPP2CA—coronary artery disease	7.27e-05	0.000232	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL2—coronary artery disease	7.24e-05	0.000231	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL3—coronary artery disease	7.24e-05	0.000231	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLCB1—coronary artery disease	7.2e-05	0.00023	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—F2R—coronary artery disease	7.15e-05	0.000228	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SDC1—coronary artery disease	7.15e-05	0.000228	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ITGAV—coronary artery disease	7.14e-05	0.000228	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PRKCD—coronary artery disease	7.14e-05	0.000228	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KNG1—coronary artery disease	7.12e-05	0.000227	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—POMC—coronary artery disease	7.1e-05	0.000227	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CREB1—coronary artery disease	7.1e-05	0.000227	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGTR1—coronary artery disease	7.08e-05	0.000226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGB—coronary artery disease	7e-05	0.000223	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2A—coronary artery disease	6.98e-05	0.000223	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—C3—coronary artery disease	6.98e-05	0.000223	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCA1—coronary artery disease	6.97e-05	0.000223	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL2—coronary artery disease	6.94e-05	0.000222	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDNRB—coronary artery disease	6.93e-05	0.000221	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6R—coronary artery disease	6.92e-05	0.000221	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL10—coronary artery disease	6.92e-05	0.000221	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLG—coronary artery disease	6.9e-05	0.00022	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—THBS1—coronary artery disease	6.82e-05	0.000218	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PSMA6—coronary artery disease	6.76e-05	0.000216	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PSMB5—coronary artery disease	6.76e-05	0.000216	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GGT1—coronary artery disease	6.75e-05	0.000216	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GOT1—coronary artery disease	6.75e-05	0.000216	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—F2—coronary artery disease	6.74e-05	0.000215	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB2—coronary artery disease	6.72e-05	0.000214	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCE—coronary artery disease	6.63e-05	0.000212	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGT—coronary artery disease	6.63e-05	0.000212	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—JAK2—coronary artery disease	6.62e-05	0.000211	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SOCS1—coronary artery disease	6.61e-05	0.000211	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—S100B—coronary artery disease	6.6e-05	0.000211	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDNRA—coronary artery disease	6.54e-05	0.000209	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SOCS3—coronary artery disease	6.53e-05	0.000209	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CYBA—coronary artery disease	6.51e-05	0.000208	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB1—coronary artery disease	6.51e-05	0.000208	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DUSP6—coronary artery disease	6.49e-05	0.000207	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KITLG—coronary artery disease	6.46e-05	0.000206	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFBR2—coronary artery disease	6.46e-05	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLAT—coronary artery disease	6.38e-05	0.000204	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	6.31e-05	0.000201	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP3—coronary artery disease	6.31e-05	0.000201	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BDKRB2—coronary artery disease	6.15e-05	0.000196	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL12—coronary artery disease	6.15e-05	0.000196	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—POMC—coronary artery disease	6.14e-05	0.000196	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—F2—coronary artery disease	6.12e-05	0.000195	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—coronary artery disease	6.11e-05	0.000195	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6ST—coronary artery disease	6.1e-05	0.000195	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOB—coronary artery disease	6.1e-05	0.000195	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTP1—coronary artery disease	6.07e-05	0.000194	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	6.05e-05	0.000193	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JUNB—coronary artery disease	6.04e-05	0.000193	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLCB1—coronary artery disease	6.02e-05	0.000192	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	6.02e-05	0.000192	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARGC1A—coronary artery disease	6.01e-05	0.000192	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EDN1—coronary artery disease	6e-05	0.000192	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMOX1—coronary artery disease	5.98e-05	0.000191	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL5—coronary artery disease	5.95e-05	0.00019	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAT—coronary artery disease	5.9e-05	0.000188	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR7—coronary artery disease	5.89e-05	0.000188	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF1—coronary artery disease	5.87e-05	0.000187	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CSF2—coronary artery disease	5.87e-05	0.000187	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LPL—coronary artery disease	5.82e-05	0.000186	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	5.77e-05	0.000184	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	5.77e-05	0.000184	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOB—coronary artery disease	5.73e-05	0.000183	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	5.62e-05	0.000179	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ITGAV—coronary artery disease	5.61e-05	0.000179	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—coronary artery disease	5.61e-05	0.000179	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KNG1—coronary artery disease	5.6e-05	0.000179	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—POMC—coronary artery disease	5.58e-05	0.000178	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CREB1—coronary artery disease	5.58e-05	0.000178	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTM1—coronary artery disease	5.58e-05	0.000178	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGTR1—coronary artery disease	5.56e-05	0.000178	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—MAPK1—coronary artery disease	5.5e-05	0.000175	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	5.49e-05	0.000175	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LPL—coronary artery disease	5.47e-05	0.000175	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	5.46e-05	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL2—coronary artery disease	5.46e-05	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6R—coronary artery disease	5.44e-05	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL10—coronary artery disease	5.44e-05	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLG—coronary artery disease	5.42e-05	0.000173	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	5.36e-05	0.000171	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GPX1—coronary artery disease	5.34e-05	0.00017	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB2—coronary artery disease	5.28e-05	0.000168	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	5.25e-05	0.000168	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—C3—coronary artery disease	5.24e-05	0.000167	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCE—coronary artery disease	5.21e-05	0.000166	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—JAK2—coronary artery disease	5.21e-05	0.000166	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CD36—coronary artery disease	5.2e-05	0.000166	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SOCS1—coronary artery disease	5.2e-05	0.000166	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—S100B—coronary artery disease	5.19e-05	0.000166	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPP2CA—coronary artery disease	5.14e-05	0.000164	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SOCS3—coronary artery disease	5.13e-05	0.000164	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KITLG—coronary artery disease	5.07e-05	0.000162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFBR2—coronary artery disease	5.07e-05	0.000162	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	5e-05	0.00016	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGT—coronary artery disease	4.98e-05	0.000159	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT5A—coronary artery disease	4.96e-05	0.000158	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP3—coronary artery disease	4.96e-05	0.000158	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—coronary artery disease	4.93e-05	0.000157	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LEP—coronary artery disease	4.88e-05	0.000156	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOE—coronary artery disease	4.88e-05	0.000156	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOA1—coronary artery disease	4.82e-05	0.000154	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOB—coronary artery disease	4.79e-05	0.000153	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KDR—coronary artery disease	4.78e-05	0.000153	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	4.77e-05	0.000152	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	4.75e-05	0.000152	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	4.75e-05	0.000152	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	4.73e-05	0.000151	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	4.72e-05	0.000151	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AGT—coronary artery disease	4.68e-05	0.000149	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	4.68e-05	0.000149	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—coronary artery disease	4.66e-05	0.000149	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	4.61e-05	0.000147	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	4.61e-05	0.000147	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FN1—coronary artery disease	4.6e-05	0.000147	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—F2—coronary artery disease	4.6e-05	0.000147	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOE—coronary artery disease	4.59e-05	0.000146	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	4.58e-05	0.000146	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LPL—coronary artery disease	4.58e-05	0.000146	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	4.55e-05	0.000145	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	4.54e-05	0.000145	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	4.54e-05	0.000145	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOA1—coronary artery disease	4.53e-05	0.000145	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	4.42e-05	0.000141	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KIT—coronary artery disease	4.4e-05	0.000141	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	4.32e-05	0.000138	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	4.29e-05	0.000137	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	4.23e-05	0.000135	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	4.22e-05	0.000135	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—POMC—coronary artery disease	4.19e-05	0.000134	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CREB1—coronary artery disease	4.19e-05	0.000134	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	4.13e-05	0.000132	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—C3—coronary artery disease	4.12e-05	0.000132	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL2—coronary artery disease	4.1e-05	0.000131	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6R—coronary artery disease	4.09e-05	0.000131	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—coronary artery disease	4.03e-05	0.000129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	4.01e-05	0.000128	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARG—coronary artery disease	4e-05	0.000128	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—POMC—coronary artery disease	3.94e-05	0.000126	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	3.93e-05	0.000125	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	3.92e-05	0.000125	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—coronary artery disease	3.9e-05	0.000124	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	3.84e-05	0.000122	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	3.84e-05	0.000122	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.84e-05	0.000122	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	3.83e-05	0.000122	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	3.79e-05	0.000121	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	3.76e-05	0.00012	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	3.73e-05	0.000119	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF2—coronary artery disease	3.71e-05	0.000118	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	3.66e-05	0.000117	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOS3—coronary artery disease	3.66e-05	0.000117	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	3.62e-05	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—F2—coronary artery disease	3.62e-05	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	3.6e-05	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALB—coronary artery disease	3.59e-05	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	3.57e-05	0.000114	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JAK2—coronary artery disease	3.55e-05	0.000113	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.48e-05	0.000111	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	3.46e-05	0.000111	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NOS3—coronary artery disease	3.44e-05	0.00011	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	3.32e-05	0.000106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	3.3e-05	0.000105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	3.3e-05	0.000105	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	3.24e-05	0.000104	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	3.22e-05	0.000103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	3.21e-05	0.000103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	3.17e-05	0.000101	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	3.15e-05	0.000101	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—coronary artery disease	3.14e-05	0.0001	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	3.13e-05	0.0001	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	3.1e-05	9.91e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	3.08e-05	9.84e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	3.02e-05	9.64e-05	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.01e-05	9.62e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	3.01e-05	9.61e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	2.93e-05	9.36e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	2.91e-05	9.3e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	2.87e-05	9.17e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	2.85e-05	9.08e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	2.79e-05	8.92e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.74e-05	8.74e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	2.63e-05	8.41e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	2.55e-05	8.14e-05	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	2.46e-05	7.86e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	2.44e-05	7.79e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	2.42e-05	7.74e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.42e-05	7.72e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	2.37e-05	7.58e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.37e-05	7.57e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	2.31e-05	7.36e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	2.24e-05	7.14e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	2.07e-05	6.61e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	2.06e-05	6.57e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.93e-05	6.17e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.9e-05	6.07e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.86e-05	5.95e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.82e-05	5.82e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.68e-05	5.37e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.62e-05	5.16e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—coronary artery disease	1.58e-05	5.04e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.43e-05	4.57e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.32e-05	4.22e-05	CbGpPWpGaD
